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Infections with the Zika virus (ZIKV) are responsible for congenital abnormalities and neurological dis-
orders. We here demonstrate that ZIKV productively infects three types of human iPSC (induced
pluripotent stem cells)-derived cells from the neural lineage, i.e. cortical and motor neurons as well as
astrocytes. ZIKV infection results in all three cell types in the production of infectious virus particles and
induces cytopathic effects (CPE). In cortical and motor neurons, an Asian isolate (PRVABC59) produced
roughly 10-fold more virus than the prototypic African strain (MR766 strain). Viral replication and CPE is
efﬁciently inhibited by the nucleoside polymerase inhibitor 7-deaza-20-C-methyladenosine (7DMA).
However, ribavirin and favipiravir, two molecules that inhibit ZIKV replication in Vero cells, did not
inhibit ZIKV replication in the neuronal cells. These results highlight the need to assess the potential
antiviral activity of novel ZIKV inhibitors in stem cell derived neuronal cultures.
© 2017 The Authors. Published by Elsevier B.V. This is an open access article under the CC BY-NC-ND
license (http://creativecommons.org/licenses/by-nc-nd/4.0/).The Zika virus (ZIKV) is a mosquito-borne ﬂavivirus that was
ﬁrst isolated in 1947 in Uganda (Dick et al., 1952). The last years this
previously neglected virus has spread through the Paciﬁc islands to
South America, where it is currently causing a large epidemic
(WHO, 2016). Infection during pregnancy has been shown to result
in an increased chance of fetal abnormalities such as microcephaly,
brain calciﬁcations and ophthalmological problems (de Paula
Freitas et al., 2016; Mlakar et al., 2016; Oliveira Melo et al., 2016).
In adults, neurological complications such as Guillain-Barre syn-
drome, meningoencephalitis and acutemyelitis have been reported
(Cao-Lormeau et al., 2016; Carteaux et al., 2016; Mecharles et al.,
2016). According to the WHO, the ZIKV epidemic associated with
microcephaly and neurological complications continues to repre-
sent a major challenge for public health, therefore the Strategic
Response Planwas set up to prevent and manage the complications
of ZIKV (WHO, 2016). The exact mechanism of vertical trans-
mission, teratogenic effects and neuro-invasion remains to be
explored. To date ZIKV has been detected in the amniotic ﬂuid
(RNA) (Calvet et al., 2016; Sarno et al., 2016) and fetal brain tissueical Research, University of
lgium.
).
B.V. This is an open access article u(RNA and viral particles) (Driggers et al., 2016; Mlakar et al., 2016)
of fetuses that develop abnormalities upon ZIKV infection of the
pregnant mothers. Several hypothesis of vertical transmission have
been proposed (Adibi et al., 2016; Retallack et al., 2016; Tabata et al.,
2016). Neural tropism is a characteristic of several ﬂaviviruses: tick-
borne encephalitis virus (TBEV) is among the common infective
agents of meningoencephalitis in Europe, West Nile virus (WNV)
and Japanese encephalitis virus (JEV) are known to cause enceph-
alitis (Ludlow et al., 2016; Winkelmann et al., 2016), and neuro-
logical complications can also rarely occur in Dengue virus
infection (Madi et al., 2014). In addition, TBEV has been found in
brain tissue and spinal cord of infected patients (Gelpi et al., 2005),
and WNV is associated with neuronal loss (Kelley et al., 2003).
However, the birth defects caused by ZIKV have not been reported
for other ﬂavivirus infections.
To further explore biological processes underlying fetal infection
and neurological complications, relevant cellular and animal
models of ZIKV infection are being developed. Here we report on
ZIKV infection, and inhibition thereof, in three types of induced
pluripotent stem cell (iPSC)-derived neuronal cell types: cortical
neurons, motor neurons and astrocytes. Cortical neurons form the
human cerebral cortex responsible for higher nervous activity. The
disturbance of proliferation and differentiation of these cells has
been linked to various disorders including microcephaly (Manzininder the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/).
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represent the predominant cell population in the human brain.
Among other functions, astrocytes are involved in the neuro-
inﬂammatory response during central nervous system (CNS)
infection (Hamel et al., 2017; Molofsky and Deneen, 2015). Motor
neurons control effector organs such as the muscles. In the context
of ZIKV infection numerous cases of motor disability have been
reported (Cao-Lormeau et al., 2016; Mecharles et al., 2016).
To investigate which cell types might be primary targets of ZIKV
infection in the nervous system, we differentiated wild-type hu-
man iPSC into early cortical neurons, motor neurons and astrocytes
and studied the susceptibility of these different cell types for ZIKV
infection. To this end, the prototypic ZIKV strain MR766 from the
African lineage and the recent clinical strain PRVABC59 from the
Asian lineage (Puerto Rico, December 2015) were used each at a
multiplicity of infection (MOI) of 10E-4 (as determined in Vero
cells). We used a low inoculum since this may provide a more
sensitive readout of susceptibility to infection than overloading
cells with a high inoculum. Using a low inoculum also had the
advantage that the special neuronal culture medium was not sub-
stantially diluted. Following infection, cell cultures were monitored
microscopically and supernatant samples were collected at day 1, 3
and 6 post infection for cortical neurons and astrocytes and at day 1,
4 and 7 post infection for motor neurons until cytopathogenic ef-
fects (CPE) were observed. Viral RNA levels and the infectivity of
viral progeny were quantiﬁed by means of qRT-PCR and end-point
titration in Vero cells, respectively.
The three cell types proved susceptible to both ZIKV strains and
produced infectious progeny virus (Fig. 1). The PRVABC59 strain
produced signiﬁcantly higher viral loads (both RNA and infectious
virions) than the MR766 strain at the end of the experiment inFig. 1. hiPSC-derived cells of neural lineage are susceptible to ZIKV infection. Infectious vir
infection of hiPSC-derived (A, D) cortical neurons, (B,E) motor neurons and (C, F) astrocytes a
three independent experiments and are presented as mean (±) SEM. *p < 0,05.cortical neurons (day 6 p.i.) and in motor neurons (day 7 p.i.). No
signiﬁcant difference in viral loads between the two ZIKV strains
was observed in astrocytes. The highest titers of infectious virus
were observed in motor neurons (up to 10Eþ7 TCID50/ml for
PRVABC59 and 10Eþ6 TCID50/ml for MR766); titers in cortical
neurons increased up to 10Eþ6 for PRVABC59 and 10Eþ5 TCID50/ml
for MR766, whereas the lowest viral production was observed in
astrocytes. Similar results were obtained by measuring viral
genome copies in culture supernatants by qRT-PCR (Fig. 1). The
dynamics of ZIKV replication was comparable in cortical neurons
and astrocytes with a rapid increase of viral RNA load during the
ﬁrst 3 days and complete destruction of the cell cultures by CPE at
day 6 p.i. The infection in motor neurons progressed slower with
ﬁrst signs of CPE appearing at day 5e6 p.i. and complete destruc-
tion of the cultures by CPE at day 7e8 p.i. Our ﬁndings are in line
with recent other studies where ZIKV was shown to infect human
neural progenitor cells (hNPCs) and early cortical neurons (Tang
et al., 2016; Dang et al., 2016; Xu et al., 2016). Infection of astro-
cytes was also demonstrated (Xu et al., 2016; Qian et al., 2016).
When using a 10-fold lower MOI (10E-5) cortical neurons and
motor neurons still proved susceptible to ZIKV infection, whereas
this MOI proved too low to result in a productive infection in as-
trocytes (as monitored over a period of 6 days) (Fig. S1).
We next studied the potential antiviral activity of 3 molecules
for which we demonstrated earlier that they inhibit ZIKV replica-
tion in Vero cells (Zmurko et al., 2016) namely T-705 (favipiravir), 7-
deaza-20-C-methyladenosine (7DMA) and ribavirin (Table 1). T-705
is a broad-spectrum inhibitor with antiviral activity against many
RNA viruses including ﬂaviviruses [the West-Nile virus and the
yellow fever virus (Furuta et al., 2013)], and 7DMA was initially
developed as a polymerase inhibitor of the hepatitis C virus (Olsenus and viral RNA levels of ZIKV MR766 (black) and PRVABC59 (grey) strains following
s quantiﬁed by qRT-PCR or by end-point titration respectively. Data are mean values of
Table 1
Antiviral activity of 7DMA, T-705 and Ribavirin in neuronal cultures.
Cortical neurons Motor neurons Astrocytes
EC50 CC50 EC50 CC50 EC50 CC50
MR766 PRVABC59 MR766 PRVABC59 MR766 PRVABC59
7DMA 2,2 ± 0,6 1,6 ± 0,3 52 ± 1 1,2 ± 0,1 1,7 ± 0,01 52 ± 1 1,7 ± 0,3 1,4 ± 0,1 >100
T-705 NA NA >100 NA NA >100 NA NA >100
Ribavirin NA NA >100 NA NA >100 NA NA >100
*EC50 and CC50 values in mg/ml. Antiviral activity was determined by measuring reduction of viral RNA load in culture supernatants. Data represent median values ± standard
deviations (SD) of three independent experiments. NA e not active.
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antiviral activity against ﬂaviviruses (Crance et al., 2003; Leyssen
et al., 2006). Following infection of the differentiated cells, ﬁxed
concentrations of the compounds were added to the medium
(10 mg/ml 7DMA, 40 mg/ml favipiravir or 20 mg/ml ribavirin). No
cytotoxic effects in any cell type were observed. Interestingly, only
7DMA resulted in an antiviral effect as shown by an inhibitory effect
on ZIKV-induced CPE in all three cell types and a reduction of in-
fectious viral yield and viral RNA levels by 5 log10 and 4 log10,
respectively (at a concentration of 10 mg/ml) (Fig. 2). 7DMA treated
cultures did not show signs of CPE at the end of experiment. The
strongest inhibition by 7DMAwas observed in astrocytes, in which
the titers of both strains were reduced to undetectable levels in
treated cells. The more pronounced antiviral effect in astrocytes
may possibly be the result of the overall lower production of ZIKV inFig. 2. ZIKV replication in hiPSC-derived neural cells is inhibited by the nucleoside polymera
ml, dotted bar), favipiravir (40 mg/ml, dark grey bar) and ribavirin (20 mg/ml, light grey bar
derived (A, D) cortical neurons, (B, E) motor neurons and (C, F) astrocytes as quantiﬁed
(7DMA) or two (favipiravir, ribavirin) independent experiments and are presented as meanthis type of cells. The inhibitory effect of 7DMA was more pro-
nounced against the MR766 strain than against the PRVABC59
strain in all three cell types. Surprisingly, whereas T-705 and riba-
virin inhibited ZIKV replication in Vero cells, these antiviral mole-
cules did not inhibit the replication of both MR766 and PRVABC59
ZIKV in the neuronal cells (Fig. 2). It may be assumed that differ-
ences in the uptake or cellular metabolism of the compounds
(ribavirin needs to be phosphorylated and T-705 is converted to a
nucleotide) between Vero cells on the one hand and neurons and
astrocytes on the other hand explain this difference.
Microcephaly can be caused by many factors, among them the
disruption of differentiation, and the proliferation and apoptosis
balance in neurons (Manzini andWalsh, 2011). Increased cell death
caused by ZIKV infection might therefore directly contribute to the
development of microcephaly. The infection of astrocytes, althoughse inhibitor 7DMA, but not by favipiravir or ribavirin. Inhibitory effect of 7DMA (10 mg/
) on the production of ZIKV RNA of strain MR766 or PRVABC59 (black bars) in hiPSC-
by qRT-PCR or by end-point titration respectively. Data are mean values for three
(±) SEM. *p < 0,05 **p < 0,005 # not detected.
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opment of ZIKV associated CNS abnormalities, since these cells
represent the predominant population in the brain (Sofroniew and
Vinters, 2010).
To date 21 countries have reported an increased incidence of
Guillain-Barre syndrome (GBS) in coincidence with an ongoing
ZIKV outbreak (WHO, 2017). GBS is usually caused by an autoim-
mune attack on the nerves damaging myelin or axons and is often
triggered by infection (Hardy et al., 2011). It is not yet known
whether Guillain-Barre syndrome associated with ZIKV infection is
caused by an autoimmune reaction or by direct action of the virus
on the nerves. We here demonstrate as the ﬁrst that ZIKV is able to
infect motor neurons. This suggests the potential for a direct effect
of the virus on nerves, which may possibly contribute to/trigger the
induction of GBS in ZIKV infected patients.
It is not clear yet why cortical and motor neurons are more
susceptible to ZIKV than astrocytes. This could be due to cell-type
speciﬁc expression of ZIKV receptors (Nowakowski et al., 2016) or
different innate immune programs (Cho et al., 2013). Further
studies are thus needed to reveal the exactmechanism determining
ZIKV neurotropism.
It is subject of further investigation whether particular differ-
ences between strains of the Asian and African lineages contribute
to differences in ZIKV neurotropism (Wang et al., 2016). Infection
rates in human forebrain organoids infected with the MR766 strain
(African lineage) and FSS13025 (Asian lineage) proved comparable
(Qian et al., 2016). Another study showed also comparable infection
rates of these strains in human brain microvascular endothelial
cells (HBMECs) (Bayer et al., 2016). Infection of primary human
astrocytes with the H/PF/2013 strain (Asian lineage) and the HD
78788 strain (African lineage) resulted in comparable levels of
production of infectious virus (Hamel et al., 2017). Hamel and col-
leagues observed higher titers of infectious virus in primary human
astrocytes then we report in iPSC-derived astrocytes. This might be
attributed to the differences in experimental design (cell system,
virus isolates, MOIs). The isolates used in our study may induce
stronger antiviral response in astrocytes; it is also possible that low
MOI and slower infection kinetics allow enough time for innate
immunity activation, resulting in lower production of infectious
virus. The low passaged African strain ArB41644 showed higher
infectivity in human neural stem cells (NSC) and astrocytes
compared to Asian strain H/PF/2013 (Simonin et al., 2016). We here
observed that the Asian isolate PRVABC59 produced roughly 10-
fold more virus than the prototypic African strain (MR766 strain)
in cortical and motor neurons. A larger panel of several low
passaged clinical isolates will need to be studied in parallel in the
future.
In conclusion, we demonstrate (i) for the ﬁrst time that motor
neurons support ZIKV replication and these cells are as a conse-
quence of ZIKV replication destroyed by the virus and (ii) that
human iPSC derived neuronal cells offer a physiologically relevant
system to assess the potential antiviral effect of small molecule
inhibitors of viral replication that are being developed to clear ZIKV
infections in the nervous system.
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